Buys
Open market- Shares
- Avg price
- Total value
Anthony Mancini - Chief Global Commercialization Officer at Revolution Medicines, Inc.
Issuer-level insider activity
- Role
- Chief Global Commercialization Officer
- Issuer ticker
- RVMD, RVMDW on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Anthony Mancini in Revolution Medicines, Inc.
Sells
Open market- Shares
- -48,306
- Avg price
- $107.50
- Total value
- -$5,193,050
Net
Past year- Shares
- -48,306
- Share %
- -100%
- Total value
- -$5,193,050
Reported holdings for Anthony Mancini in Revolution Medicines, Inc.
Form 4 holding
Chief Global Commercialization Officer
Revolution Medicines, Inc.
- Security class
- Common Stock
- Shares / value
- 49,975
- Estimated value
- $7,802,057
- Report date
- 16 Jun 2026
- Price
- $156.12
- Ownership
- Direct
Form 4 holding
Chief Global Commercialization Officer
Revolution Medicines, Inc.
- Security class
- Stock Option (Right to Buy)
- Shares / value
- 106,109
- Estimated value
- Report date
- 26 May 2026
- Price
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
Transaction history for Anthony Mancini in Revolution Medicines, Inc.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.